Cleanspace Holdings Ltd. · ASX:CSX
Cleanspace — Investor Presentation (August 2022)
12 slides from Cleanspace's investor presentation, Aug 25, 2022
Slide 1: Full Year FY22 Results Presentation
FULL YEAR FY22 RESULTS PRESENTATION CLEANSPACE HOLDINGS LIMITED (ASX:CSX) CleanSpace designs and manufactures innovative respiratory protection solutions for healthcare & industrial employers globally We understand the importance of best-in-class personal protective equipment that not only performs,
Slide 2: Important Notice & Disclaimer
IMPORTANT NOTICE & DISCLAIMER ACCEPTANCE release includes certain non-IFRS measures including EBITDA and Free Cash Flow. These measures are This presentation has been prepared by CleanSpace Holdings Limited (ACN 150 214 636) (CleanSpace). presented to enable understanding of the underlying performan
Slide 3: Overview
OVERVIEW FINANCIAL RESULTS NEW INITIATIVES ▪ FY22 Revenue ($13.4m) was significantly down (PCP FY22 $49.9m). ▪ North America. Investment in a new, highly skilled sales force in Q3. Now ▪ Gross margin remains high (73%). fully trained, deployed and meeting sales targets. ▪ Strong balance sheet with c
Slide 4: New Initiatives in 2H FY22
NEW INITIATIVES IN 2H FY22 New initiatives are expected to mitigate any residual headwinds and are generating positive sales momentum. ▪ North America. Material investment made in an experienced highly skilled sales force in Q3. The team are now fully trained, deployed and meeting sales targets for
Slide 5: Market Overview
MARKET OVERVIEW Leaders confirming these factors - ‘now living with ongoing outbreaks’, unsustainable consumable PPE costs and staff absenteeism - are driving change to superior respiratory protection in routine patient care. Europe ▪ Strong uplift in sales in 2H FY22. Historically a strong growth i
Slide 6: Advancing Leadership in Technology
ADVANCING LEADERSHIP IN TECHNOLOGY CleanSpace continues to invest in R&D programs delivering differentiated customer driven solutions. ▪ Commercialising new products: Steri-plus solution for sterile environments and source control with workers caring for vulnerable patients; AX gas filter approved f
Slide 7: FY22 Financial Summary
FY22 FINANCIAL SUMMARY ▪ FY22 revenue ($13.4m) was significantly down (PCP FY21 $49.9m) recognising major pandemic fuelled sales made in FY21 and market turbulence. ▪ Maintained robust high gross margin of 73%. Slightly down (PCP FY21 77%) due to a shift toward industrial sales (through distribution
Slide 8: Income Statement
INCOME STATEMENT Change (A$m) vs PCP F / U H1 FY22 H2 FY22 FY22 H1 FY21 H2 FY21 FY21 % ▪ Retained robust high gross margin (73%). Revenue 7.0 6.4 13.4 39.7 10.2 49.9 73 U ▪ Price increases implemented and Gross Profit 5.3 4.5 9.8 31.1 7.3 38.4 75 U effective in 1H FY23. Employee benefits expenses (6
Slide 9: Summary Balance Sheet
SUMMARY BALANCE SHEET as at as at Summary Balance Sheet (A$m) 30 Jun-22 30-Jun-21 Cash, cash equivalents and term deposits 24.3 38.2 ▪ Balance sheet remains strong with cash of 2.5 2.4 $24.3m at 30 June 2022 and minimal debt. Trade and other receivables Inventories 3.7 4.6 ▪ Continuing focus on cash
Slide 10: Outlook
OUTLOOK The company believes it has experienced peak disruption to its healthcare and industrial markets globally given lockdowns are no longer favoured, increasing customer activity, supplies of disposables are being run down and a recognition that PAPRs are the best protection for staff in both th
Slide 11: www.cleanspacetechnology.com
WWW.CLEANSPACETECHNOLOGY.COM 11 CleanSpace Holdings Limited | FY22 Full Year Results Presentation | AUGUST 2022
Slide 12: Renewal in Board Leadership with Strong Skills Bringing a Fresh Approach
RENEWAL IN BOARD LEADERSHIP WITH STRONG SKILLS BRINGING A FRESH APPROACH ▪ Careers in technology growth businesses ▪ Experience in - Large markets: North America, EU and Asia BRUCE RATHIE LISA HENNESSY GRAHAM McLEAN - Key sectors: PPE, Healthcare and Chairman Independent NED Independent NED medical
Cleanspace Holdings — Investor Presentation (August 2022) on 6ix